US Rx drug spending rebounds
This article was originally published in Scrip
Executive Summary
Spending on prescription drugs rebounded in 2013, reaching $329.2bn, an increase of 3.2% over 2012 – a year that had experienced the largest ever decline, falling -1.0% – according to IMS Institute for Healthcare Informatics.